PTC Therapeutics, Inc. announced on October 30, 2023, that it has received a $50 million milestone payment from the collaboration with Roche related to the development of a treatment for Duchenne muscular dystrophy.
AI Assistant
PTC THERAPEUTICS INC
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.